Physician profile
Patrick J Schmidlein
NPI 1518312651
$1,917.49
in general payments reported to CMS, 2019-2025
17 companies · $337 in 2025
The $337 reported for 2025 was more than what 87% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $44.14 · 2020: $269 · 2021: $241 · 2022: $488 · 2023: $39.09 · 2024: $499 · 2025: $337.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $876.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $875.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $819.25 | 2019-2025 | Bexsero, Penmenvy, Shingrix |
| Pfizer INC. | $300.73 | 2020-2024 | |
| Octapharma USA, INC. | $299.68 | 2021-2025 | Fibryga |
| Takeda Pharmaceuticals U.S.A., INC. | $152.66 | 2022-2024 | |
| Sanofi Pasteur INC. | $62.76 | 2021-2024 | |
| Ars Pharmaceuticals Operations, INC. | $36.63 | 2025 | Neffy |
| Alexion Pharmaceuticals, INC. | $31.05 | 2025 | Koselugo |
| Exact Sciences Corporation | $29.39 | 2025 | Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.13 | 2020 | |
| Dexcom, INC. | $25.77 | 2025 | Dexcom G6 Transmitter |
| Global Blood Therapeutics, INC. | $23.41 | 2020 | |
| Merck Sharp & Dohme LLC | $23.18 | 2024 | Rotateq, Gardasil, Gardasil 9 |
| Bayer Healthcare Pharmaceuticals INC. | $20.48 | 2020 | |
| Daiichi Sankyo INC. | $20.04 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $17.15 | 2025 | Farxiga |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $13.85 | 2025 | |
| Novo Nordisk INC | $13.33 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Schmidlein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.